EUVIMEDEUVIMED entdecken
Crossref

Hepatic and splenic venous access tract closure using the VASCADE vascular closure system following percutaneous intervention in patients with CHD

Lindsay F Eilers, Manish Bansal, Asra Khan, Melissa K Webb, Athar M Qureshi, Srinath T Gowda, Gary E Stapleton iD

Cardiology in the Young · 2024

DOI: 10.1017/s1047951124025538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology in the Young, 2024. Verfasst von Lindsay F Eilers und 6 weiteren Autor:innen. Beteiligte Einrichtung: Charles E. Mullins Cardiac Catheterization Laboratories, Texas Children's Hospital, and Lillie Frank Abercrombie Section of Cardiology, Department of…. Hauptthemen laut MEDLINE: Cardiac Catheterization, Splenic Vein, Vascular Closure Devices, Hepatic Veins.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatic and splenic venous access are specialised techniques used to perform diagnostic and interventional procedures in the cardiac catheterisation laboratory. Bleeding events are the most commonly reported complication following hepatic or splenic venous access. The VASCADE Vascular Closure System (Cardiva Medical Inc. Santa Barbara, CA) is an approved device for closure of femoral vascular access tracts in patients ≥18 years of age. We report our experience using VASCADE to close the hepatic or splenic venous access site in the cardiac catheterisation laboratory.

Methods

This is a single centre retrospective review of all patients who had percutaneous hepatic or splenic venous access obtained in the cardiac catheterisation laboratory from March 1, 2022 through October 30, 2023 and underwent tract closure with VASCADE.

Results

Ten patients (six male) underwent 16 procedures (median age and weight 3.5 years and 12.5 kg) with 15 hepatic and two splenic veins accessed. Successful closure of the access tracts with VASCADE was performed in all patients. There were no major adverse events related to closure of the access sites with VASCADE.

Conclusion

VASCADE can be used following transhepatic and trans-splenic venous access in the cardiac catheterisation laboratory to safely close the access tract and potentially reduce the risk of post-procedural bleeding complications. Further evaluation in a larger cohort of patients is needed to ensure VASCADE is safe for use and provides adequate haemostasis following hepatic or splenic venous access, particularly in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac CatheterizationSplenic VeinVascular Closure DevicesHepatic VeinsHeart Defects, CongenitalHumansMaleRetrospective StudiesFemaleChild, PreschoolChildAdolescentInfant

Stichwörter der Autor:innen

VASCADE Vascular Closure Systemcardiac catheterisationhepaticsplenic

Autor:innen und Institutionen

  • Charles E. Mullins Cardiac Catheterization Laboratories, Texas Children's Hospital, and Lillie Frank Abercrombie Section of Cardiology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

ORCID-Profile: Gary E Stapleton

Zitieren

APA

Eilers, L. F., Bansal, M., Khan, A., Webb, M. K., Qureshi, A. M., Gowda, S. T., & Stapleton, G. E. (2024). Hepatic and splenic venous access tract closure using the VASCADE vascular closure system following percutaneous intervention in patients with CHD. Cardiology in the Young. https://doi.org/10.1017/s1047951124025538

Vancouver

Eilers LF, Bansal M, Khan A, Webb MK, Qureshi AM, Gowda ST, et al. Hepatic and splenic venous access tract closure using the VASCADE vascular closure system following percutaneous intervention in patients with CHD. Cardiology in the Young. 2024. doi:10.1017/s1047951124025538

BibTeX
@article{Eilers2024,
  author = {Eilers, Lindsay F and Bansal, Manish and Khan, Asra and Webb, Melissa K and Qureshi, Athar M and Gowda, Srinath T and Stapleton, Gary E},
  title = {Hepatic and splenic venous access tract closure using the VASCADE vascular closure system following percutaneous intervention in patients with CHD},
  journal = {Cardiology in the Young},
  year = {2024},
  doi = {10.1017/s1047951124025538}
}
Kostenlos starten →